New Cardiovascular Horizons

What New Cardiovascular Horizons does

New Cardiovascular Horizons (NCVH) is a Louisiana-domiciled educational nonprofit foundation founded in 1999 by interventional cardiologist Dr. Craig Walker to deliver accredited multidisciplinary education in cardiovascular medicine, with emphasis on endovascular technologies, peripheral interventions, pharmacotherapy, and amputation prevention. The foundation does not develop proprietary clinical technology products; instead it operates an event-driven platform centered on its flagship 1,500+ attendee annual conference in New Orleans (24+ live case transmissions, 300+ scientific lectures, 175+ preeminent faculty), supplemented by 12+ regional one-day meetings across US metros, and international sessions in China (CIT, CEC) and the UAE. A Digital Education Series (DES) extends the platform online with free on-demand lectures and live cases since 2016, jointly accredited through Cine-Med under ACCME, ACPE, and ANCC standards to deliver CME, CNE, and CE credits.

The business model is a hybrid of attendee-paid registration and industry sponsorship. Annual conference registration is tiered ($299 early bird, $599 advance, $799 standard), while regional meetings price at $35-$55 per attendee. The larger revenue stream is sponsorship and exhibitor fees from major cardiovascular device and pharmaceutical companies including Abbott Vascular, Medtronic, Boston Scientific, and Philips, with additional sponsors across pharma (Amgen, AstraZeneca, Bayer, Boehringer Ingelheim) and device (Abiomed, Asahi, BD) categories. Mobile applications on iOS and Android, plus a free member portal, extend content distribution beyond physical events. Customer segments span interventional cardiologists, podiatrists and wound care specialists, primary care physicians, nurses and cath lab technologists, and cardiology fellows/residents.

Dr. Walker is also the founder of Cardiovascular Institute of the South (CIS), a 17-location, 65-cardiologist, 800+ employee clinical practice, and NCVH leverages CIS as a core partner for live case broadcasts and faculty participation. The organization is founder-controlled with no disclosed parent company, no venture or private equity backing, and no publicly disclosed financials. Governance and content development are led by Dr. Walker as President and Medical Director, supported by regional chairmen for each local meeting and an extensive faculty network.

Name

New Cardiovascular Horizons

Legal name

New Cardiovascular Horizons Foundation

Website

https://ncvh.org

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

NCVH is a Louisiana-based nonprofit foundation founded in 1999 by Dr. Craig Walker that delivers accredited multidisciplinary cardiovascular education through a flagship annual New Orleans conference, 12+ regional US meetings, and a free on-demand digital platform, serving interventional cardiologists, podiatrists, primary care physicians, and fellows.

Ownership category

akta.pro rank

Product category

Continuing Medical Education (Cardiovascular/Vascular)

NAICS

Educational Support Services (61171)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Cardiovascular medical education
• Continuing medical education
• Peripheral interventions training
• Endovascular conferences
• Vascular disease education

Headquarters

HQ city

Lafayette

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Conference Registration Fees: NCVH generates revenue through registration fees for annual conferences and regional meetings. Annual conference pricing ranges from $299 early bird to $799 standard registration. Regional meetings charge $35-$55 for attendance with accreditation included.
2. Industry Sponsorships and Exhibitor Fees: Medical device and pharmaceutical companies sponsor NCVH events and purchase exhibit space. Sponsors include major cardiovascular companies such as Abbott Vascular, Medtronic, Boston Scientific, Philips, and others. Exhibitor packages include booth space, name badge registrations, and promotional opportunities.
3. Digital Education Series: The Digital Education Series provides free online content for healthcare professionals, with CME, CNE, and CE credits available at no charge for members who have attended NCVH conferences since 2016.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

New Cardiovascular Horizons (NCVH) is an educational nonprofit foundation that delivers multidisciplinary, accredited continuing medical education focused on cardiovascular care, endovascular technologies, peripheral interventions, and amputation prevention. Its core offerings include a flagship multi-day annual conference in New Orleans, 12+ regional one-day meetings across the United States, an on-demand Digital Education Series platform, and specialized courses (Fellows Course, Business of Peripheral Interventions, CO2 Angiography Society, Vein Forum). All programs are accredited for CME, CNE, and CE credit through the joint provider Cine-Med.

Product overview

New Cardiovascular Horizons (NCVH) is an educational nonprofit foundation focused on multidisciplinary accredited conferences to advance cardiovascular care using endovascular technologies, pharmacotherapy treatments, peripheral interventions, and amputation prevention techniques. The organization operates a unified platform of educational products centered around its flagship Annual Conference, complemented by 12+ Regional Meetings held across North America, a Digital Education Series (DES) online platform offering on-demand accredited content, specialized courses including Fellows Course, Business of Peripheral Interventions Course, CO2 Angiography Society events, and Vein Forum. These products work together to provide comprehensive education covering all aspects of peripheral interventions from carotid to below-the-knee procedures, with the DES serving as the digital extension of the in-person conference experience.

Differentiator

Problem solved

Functional benefit

Brands

• NCVH Digital Education Series (DES): Free digital media platform for delivery of all NCVH educational content online and on-demand, providing hundreds of hours of online lectures and live cases.

Products and services

• NCVH Annual Conference Multi-day annual conference providing comprehensive education across peripheral interventions including carotid, renal, femoral, and below-the-knee procedures, aortic stent grafting, abdominal and thoracic aortic aneurysm interventions, and deep venous interventions. Features HD live case transmissions, 300+ scientific lectures, and 175+ faculty presentations.
• NCVH Regional Meetings One-day regional conferences held across North America providing local updates on cardiovascular care, peripheral, arterial, and venous disease diagnosis and treatment for primary care providers, interventionists, nurse practitioners, cath lab directors, and allied health professionals.
• Fellows Course Educational program within the annual conference designed specifically for cardiology and interventional fellows in training, covering endovascular training, peripheral interventions, and clinical research exposure.
• Business of Peripheral Interventions Course A specialized course addressing the business and operational aspects of peripheral intervention practices.
• CO2 Angiography Society Event Focused educational event dedicated to CO2 angiography techniques and applications in vascular interventions.
• Vein Forum Educational forum focused on venous disease diagnosis and treatment modalities.
• Digital Education Series (DES) A free digital media platform providing hundreds of hours of online lectures and live cases from the New Orleans Annual Conference, with CME, CNE, and CE credits available for attendees of any NCVH Conference since 2016. Delivered through a member portal with on-demand access to symposium recordings and educational content.

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core.

• Cine-Med (Accredited Education Provider)coreStrategic or Co-development PartnerCine-Med is the accredited provider jointly working with NCVH to provide unbiased continuing education content for healthcare providers. Cine-Med is jointly accredited by ACCME, ACPE, and ANCC to provide continuing education for the healthcare team.
• Abbott VascularcoreGTM or Marketing PartnerMajor sponsor of NCVH conferences. Abbott Vascular develops and manufactures cardiovascular medical devices and supports NCVH educational programs.
• MedtroniccoreGTM or Marketing PartnerKey industry sponsor supporting NCVH educational initiatives. Medtronic is a global leader in medical technology serving patients worldwide.
• Boston ScientificcoreGTM or Marketing PartnerSponsor of NCVH conferences providing support for cardiovascular education programs.
• Philips HealthcarecoreGTM or Marketing PartnerPhilips has partnered with NCVH for live case broadcasts and meal symposiums, providing medical imaging and healthcare technology expertise.
• Cardiovascular Institute of the South (CIS)coreStrategic or Co-development PartnerFounded by NCVH founder Dr. Craig Walker. CIS is a world-renowned cardiovascular practice with 17 locations, 65 cardiologists, and 800+ team members. CIS has played a pivotal role in clinical research and development of new interventional technologies.
• Dr. Craig WalkercoreOthersFounder, President, Medical Director, and Interventional Cardiologist of NCVH. Dr. Walker established the conference to educate and train medical professionals on the latest techniques to treat coronary and peripheral vascular disease. He has trained more than 1,000 physicians via hands-on peripheral vascular training courses.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Society of Interventional Radiology (SIR): SIR runs the SIR Annual Scientific Meeting, a major interventional radiology conference that intersects with NCVH on peripheral vascular interventions and endovascular procedures. It is a broader society-driven incumbent rather than a directly competing focused conference.
• American College of Cardiology (ACC): ACC runs the ACC Annual Scientific Session, one of the largest cardiovascular CME events globally. Its general cardiology scope and society membership base make it a broader incumbent that overlaps with NCVH's cardiologist audience but lacks NCVH's peripheral/CLI specialization.
• SCAI (Society for Cardiovascular Angiography and Interventions): SCAI is the professional society for interventional cardiologists and hosts the annual SCAI Scientific Sessions. It overlaps with NCVH's interventional cardiology audience and CME focus but covers the full specialty breadth rather than NCVH's peripheral intervention niche.
• TCT (Transcatheter Cardiovascular Therapeutics): TCT, run by the Cardiovascular Research Foundation, is the largest interventional cardiology conference globally with broader scope and deeper sponsor base than NCVH. It overlaps significantly on attendee profiles and live-case content, but operates at materially larger scale.
• American Heart Association (AHA) Scientific Sessions: AHA Scientific Sessions is a major cardiovascular CME event covering cardiology and vascular medicine broadly. It competes for the same multidisciplinary attendee pool as NCVH but at significantly greater scale and with broader topic coverage.

Direct peers

• LINC (Leipzig Interventional Course): LINC is an international live-case-based vascular intervention congress held annually in Leipzig, with strong industry sponsorship and multidisciplinary faculty. Its structure (live cases, lectures, multidisciplinary faculty) closely mirrors NCVH's core format.
• CRT (Cardiovascular Research Technologies): CRT hosts annual cardiovascular intervention-focused meetings with live cases and industry-sponsored symposia. Its target audience of interventional cardiologists and clinical specialists overlaps heavily with NCVH's core attendee base.
• VIVA (Vascular InterVentational Advances): VIVA is a US-based annual medical symposium focused on vascular intervention and endovascular therapy, targeting interventional cardiologists, vascular surgeons, and interventional radiologists. It mirrors NCVH's audience, content mix (live cases, lectures, multidisciplinary faculty), and event-driven CME model, making it the closest direct peer.
• Charing Cross Symposium: Charing Cross is a long-running London-based international symposium focused on vascular and endovascular interventions, attracting a global faculty and audience similar to NCVH. It competes directly for international attendees and sponsors interested in peripheral vascular education.
• VEITHsymposium: VEITHsymposium is a leading annual vascular surgery and endovascular conference held annually in New York, with extensive live case transmissions and faculty-driven education. It directly competes with NCVH for vascular medicine specialists, interventional cardiologists, and industry sponsorships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/NCVHonline
• Facebookfacebook.com/ncvh.org
• LinkedInlinkedin.com/company/new-cardiovascular-horizons

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Cardiovascular Horizons